Healthcare and benefits leaders must step up to provide menopausal women with the full-spectrum care they need to protect ...

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

The current prior authorization process in U.S. healthcare constitutes a crisis, according to Jesse Ehrenfeld, immediate past ...

The law that created ASTP as a formal federal agency gave it duties such as supporting a more effective marketplace and greater competition. Stephen Konya, ASTP’s chief, innovation and strategic ...

From AI to value-based care, three VCs shared their controversial takes on healthcare during a recent panel discussion at the MedCity INVEST conference.

Threat actors continue to refine their strategies, and the financial incentives for cybercrime persist. However, the combination of stronger defenses, regulatory pressure, and industry collaboration ...

Regeneron Pharmaceuticals’ $256 million offer was chosen the winner of 23andMe’s bankruptcy auction. Drug research never ...

Robert F. Kennedy Jr. testified before the House Committee on Appropriations and the Senate Health, Education, Labor and ...

UnitedHealth Group announced that Andrew Witty will step down as CEO due to “personal reasons.” He is being replaced by ...

Americans’ trust in the overall healthcare system is dwindling — but experts believe it can be rebuilt. Public trust in the U.S. healthcare system fell from 71.5% in 2020 to 40.1% in 2024 ...

The journey of rare disease patients and their families can be a long one marked by misdiagnoses, and so it is for those who have the ultra-rare disorder with the abbreviated name PMM2-CDG.

Pfizer is playing catch-up in the crowded field of obesity medicines, but it hoped to compete with a daily pill alternative to currently available injectable GLP-1 products. Instead, Pfizer is ...